Market control on analysis devices of the total, free and complexed PSA forms in serum

被引：1
|
作者：
Le Brun, Gaelle [1 ]
Fulla, Yvonne [2 ]
Assicot, Marcel [3 ]
Conquy, Sophie [2 ]
Ramirez, Jose
Riedinger, Jean-Marc [4 ]
Morin, Jean-Francois [5 ]
机构：
[1] Afssaps, F-93285 St Denis, France
[2] CHU Cochin, Paris, France
[3] IGR, Villejuif, France
[4] Ctr Reg Lutte Contre Canc, Dijon, France
[5] CHU Morvan, Brest, France
来源：
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE | 2007年 / 22卷 / 04期
关键词：
D O I：
10.1016/j.immbio.2007.02.009
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：247 / 259
页数：13
相关论文
共 50 条
  • [11] International multi-center comparison of complexed PSA (cPSA) with total PSA and percent free PSA.
    Cheli, CD
    Brawer, MK
    Filella, X
    Mitchell, I
    Babaian, RJ
    Miller, C
    Partin, A
    Trock, BJ
    CLINICAL CHEMISTRY, 2004, 50 (06) : A79 - A79
  • [12] Reactivity of free and complexed forms of PSA: examination of CAP survey discrepancies.
    Sokoll, LJ
    Breidenstein, C
    Bruzek, DJ
    Dunn, W
    Jarrar, P
    Kidwell, W
    Ness, MA
    Chan, DW
    CLINICAL CHEMISTRY, 1999, 45 (06) : A117 - A117
  • [13] Progress in standardization and quality assessment of free PSA (prostate specific antigen), total PSA, and complexed PSA immunoassay's
    Nakamura, RM
    Abrahamsson, PA
    Chopin, D
    Elgamal, AA
    Neel, H
    Stenman, H
    Eschenbach, AV
    Wu, JT
    Zhou, ZQ
    PROSTATE CANCER, 2000, : 203 - 217
  • [14] Short-term stability of the molecular forms of PSA and effect on percent free PSA (%fPSA) and percent complexed PSA (%cPSA).
    Sokoll, LJ
    Bruzek, DJ
    Dua, R
    Dunn, W
    Mohr, P
    Wallerson, C
    Chan, DW
    CLINICAL CHEMISTRY, 2001, 47 (06) : A139 - A140
  • [15] RELATION BETWEEN SERUM LEVEL OF TOTAL PSA AND FREE PSA/TOTAL PSA RATIO WITH GRADE OF PROSTATE CANCER
    Yazdani, Mohammad
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A217 - A217
  • [16] Complexed PSA compared to the free/total PSA ratio for discrimination between benign and malignant prostatic disease.
    Dew, TK
    Walsh, K
    Mulvin, D
    Michell, M
    Sherwood, RA
    CLINICAL CHEMISTRY, 1998, 44 : A36 - A36
  • [17] Non-complexed (free) PSA/total PSA ratio determinations by different assays on material with varied proportions of purified free PSA to PSA-ACT complex.
    Fox, MP
    Schneider, E
    CLINICAL CHEMISTRY, 1998, 44 : A41 - A41
  • [18] Comparison of plasma to serum results for the Abbott ARCHITECT® total PSA and free PSA assays
    Nutter, M.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A172 - A172
  • [19] Stability of immunoreactivity of free, complex and total PSA in serum.
    Ishibashi, M
    Kano, S
    Ohtake, T
    Kamiyama, M
    Watanabe, K
    Nakajima, J
    Murai, M
    CLINICAL CHEMISTRY, 1998, 44 : A43 - A43
  • [20] Clearance of free and total serum PSA after prostatic surgery
    Ravery, V
    Meulemans, A
    Boccon-Gibod, L
    EUROPEAN UROLOGY, 1998, 33 (03) : 251 - 254
12345